Literature DB >> 14122528

RENAL EXCRETION AND TISSUE DISTRIBUTION OF RADIOACTIVITY AFTER ADMINISTRATION OF TRITIUM-LABELED OXYTOCIN TO RATS.

J P AROSKAR, W Y CHAN, J E STOUFFER, C H SCHNEIDER, V V MURTI, V DUVIGNEAUD.   

Abstract

Entities:  

Keywords:  ADRENAL GLANDS; BLOOD; CEREBRAL CORTEX; DIURESIS; EXPERIMENTAL LAB STUDY; KIDNEY; LEUCINE; LIVER; MUSCLES; OXYTOCIN; PHARMACOLOGY; PHYSIOLOGY; PITUITARY GLAND; RATS; TESTIS; TRITIUM; URINE

Mesh:

Substances:

Year:  1964        PMID: 14122528     DOI: 10.1210/endo-74-2-226

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  5 in total

1.  Early experience in humans is associated with changes in neuropeptides critical for regulating social behavior.

Authors:  Alison B Wismer Fries; Toni E Ziegler; Joseph R Kurian; Steve Jacoris; Seth D Pollak
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-22       Impact factor: 11.205

2.  [Cross circulation experiments with unanesthetized rats. 3. Clearance and volume of distribution of exogenous and endogenous ADH].

Authors:  O Aziz
Journal:  Pflugers Arch       Date:  1969       Impact factor: 3.657

3.  Subcellular organization of neurophysins, oxytocin, (8-lysine)-vasopressin and adenosine triphosphatase in porcine posterior pituitary lobes.

Authors:  J C Pickup; C I Johnston; S Nakamura; L O Uttenthal; D B Hope
Journal:  Biochem J       Date:  1973-03       Impact factor: 3.857

4.  Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia.

Authors:  R Walter; P L Hoffman; J B Flexner; L B Flexner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

5.  Validation of a commercial enzyme immunoassay to assess urinary oxytocin in humans.

Authors:  Franka S Schaebs; Gwen Wirobski; Sarah Marshall-Pescini; Friederike Range; Tobias Deschner
Journal:  Endocr Connect       Date:  2021-03       Impact factor: 3.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.